Christina Applegate’s MS Misdiagnosis Highlights Broader Challenges in Detecting the Disease
Actress Christina Applegate, who became one of the most visible public faces of multiple sclerosis following her 2021 diagnosis, revealed a stunning development when she shared that she does not actually have the disease. Speaking on the podcast MeSsy hosted by fellow actress Jamie Lynn Sigler, who lives with MS, Applegate described being back at square one while doctors continue searching for the root cause of her debilitating symptoms.
Applegate’s experience highlights a wider issue within neurology. Despite approximately one million Americans living with multiple sclerosis—equaling roughly one in every 350 people—misdiagnoses remain common. According to a meta-analysis, an estimated 15 percent of MS diagnoses may be false positives. Furthermore, a 2025 study conducted by Dr. Andrew Solomon and his colleagues found that 40 percent of individuals later confirmed to have multiple sclerosis were initially misdiagnosed with a different condition.
Multiple sclerosis is an autoimmune condition in which the body mistakenly attacks protective cells surrounding the brain and spinal cord. This damage disrupts nerve signals, producing symptoms such as motor impairment, tingling sensations, and vision problems. While some patients experience alternating relapses and remissions, others face a steady progression toward serious disability. Medical science still lacks a definitive understanding of what triggers the autoimmune response, though smoking is a known risk factor, and obesity alongside metabolic issues play contributory roles. The precise role of genetics also remains unclear.
Diagnosing the condition is exceptionally difficult because no single test can reliably confirm it. Physicians typically rely on magnetic resonance imaging to scan for characteristic lesions, but those scans are subject to interpretation. Other rare conditions and blood vessel diseases in the brain can mimic MS on imaging. Patients can also undergo spinal fluid analysis to check for immune system abnormalities present in the vast majority of MS cases, though doctors sometimes skip the procedure due to low insurance reimbursement rates.
Early symptoms can easily compound the diagnostic challenge. Vague signs like fatigue, brain fog, or short-lived numbness and tingling often disappear before patients navigate the healthcare system to see a neurologist. Dr. Saud Sadiq, chief research scientist and director of the Tisch Multiple Sclerosis Research Center of New York, noted that unless these neurological symptoms are taken seriously early on, they are frequently overlooked when they temporarily abate.
Pressure to provide an immediate answer for debilitating symptoms can also push clinicians to diagnose MS even when patients do not strictly meet diagnostic criteria. The availability of effective early treatments adds to that urgency, as doctors worry about missing a therapeutic window, according to Solomon. The National Multiple Sclerosis Society released updated diagnostic criteria in 2024 to help physicians better distinguish MS from conditions like migraines and vascular disease, while artificial intelligence offers potential for more accurate imaging analysis.
Medical experts emphasize specific warning signs that warrant professional evaluation. Dr. Sadiq advises seeking medical care if numbness or pins and needles persist for more than 24 to 48 hours, or if motor problems emerge, such as difficulty using one hand to play an instrument. Dr. Annette Langer-Gould of Kaiser Permanente highlights numbness located in the abdomen, chest, or back rather than the extremities as a particular cause for concern, alongside vision blurring in only one eye.
Experts also recommend that patients ensure their MRI scans are reviewed by an MS specialist, noting that provider unfamiliarity with reading these scans is a leading cause of misdiagnosis. Physicians also encourage patients to consider spinal taps for diagnostic certainty, seek second opinions at recognized MS centers, and directly question their doctors about the evidence supporting an MS diagnosis. For patients already diagnosed who feel shaken by recent news, specialists recommend having a frank discussion with their physician regarding how their specific case met the established diagnostic criteria.
